Skip to main content

ACCENDRA HEALTH INC/VA/

جودة البيانات: 83%
ACH
NYSE Wholesale Trade Durable Goods Wholesale
KWD 2.84
▲ KWD 0.03 (1.07%)
القيمة السوقية: 202.94 M
السعر
KWD 2.66
القيمة السوقية
202.94 M
نطاق اليوم
نطاق 52 أسبوعًا
حجم التداول
فتح —
متوسط 50 يوم / 200 يوم
متوسط 50 يوم / 200 يوم

Quick Summary

النقاط الرئيسية

Revenue declined -27.11% annually over 5 years
Revenue growth is decelerating — 1Y growth trails 5Y average by 47.08%
Capital efficient — spends only 6.91% of revenue on capex
ROIC of 1.42% — low return on invested capital
Interest coverage of 0.26× — tight debt servicing
16 consecutive years of dividends — reliable payer

النمو

Revenue Growth (5Y)
-27.11%
أقل من متوسط القطاع (2.60%)
Revenue (1Y)-74.19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROIC1.42%
Net Margin-39.85%
Op. Margin0.99%

الأمان

Debt / Equity
N/A
Current Ratio0.86
Interest Coverage0.26

التقييم

PE (TTM|NTM|2027)
-0.18 | 2.70 | 2.56
أقل من متوسط القطاع (-0.17)
P/B RatioN/A
EV/EBITDA0.70
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Wholesale Trade (92 نظير)
المقياس السهم وسيط القطاع
P/E -0.2 -0.2
P/B 1.0
ROE % -3.2
Net Margin % -39.9 -2.2
Rev Growth 5Y % -27.1 2.6
D/E 0.3

السعر المستهدف للمحللين

5 محللين
Hold
الحالي
KWD 2.84
+14.4%
المستهدف
KWD 3.25
KWD 2.25
KWD 3.00
KWD 5.00
التوقعات
مكرر الربحية المستقبلي 2.70
ربحية السهم المستقبلية KWD 1.04
نمو ربحية السهم (تقدير) +55.4%
الإيرادات المقدّرة 2.71 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2027 KWD 1.04
KWD 0.81 – KWD 1.27
2.71 B 6
FY2026 KWD 0.67
KWD 0.50 – KWD 0.76
2.59 B 6

مفاجآت الأرباح

آخر 4 أرباع
الربع EPS المقدر EPS الفعلي المفاجأة
Q42025 KWD 0.22 KWD 0.21 -5.1%
Q32025 KWD 0.24 KWD 0.25 +6.4%
Q22025 KWD 0.28 KWD 0.26 -5.7%
Q12025 KWD 0.20 KWD 0.23 +14.5%

Dividend History

16 yr streak
Ex-Date Payment Date Amount Yield
Dec 14, 2021 KWD 0.00 N/A
Sep 14, 2021 KWD 0.00 N/A
Jun 14, 2021 KWD 0.00 N/A
Mar 12, 2021 KWD 0.00 N/A
Dec 14, 2020 KWD 0.00 N/A
Sep 14, 2020 KWD 0.00 N/A
Jun 12, 2020 KWD 0.00 N/A
Mar 13, 2020 KWD 0.00 N/A
Dec 13, 2019 KWD 0.00 N/A
Sep 13, 2019 KWD 0.00 N/A
Jun 13, 2019 KWD 0.00 N/A
Mar 14, 2019 KWD 0.00 N/A
Dec 14, 2018 KWD 0.08 N/A
Sep 14, 2018 KWD 0.26 N/A
Jun 14, 2018 KWD 0.26 N/A
Mar 14, 2018 KWD 0.26 N/A
Dec 14, 2017 KWD 0.26 N/A
Sep 14, 2017 KWD 0.26 N/A
Jun 13, 2017 KWD 0.26 N/A
Mar 13, 2017 KWD 0.26 N/A

All Fundamental Metrics

Growth
Revenue Growth (1Y) -74.19% Revenue Growth (3Y) -48.30%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -27.11% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.76 B Net Income (TTM) -1.10 B
ROE N/A ROA -26.88%
Gross Margin N/A Operating Margin 0.99%
Net Margin -39.85% Free Cash Flow (TTM) N/A
ROIC 1.42% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.86
Interest Coverage 0.26 Asset Turnover 0.67
Working Capital -334.29 M Tangible Book Value -1.82 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) -75.88% Dividend Growth (5Y) -58.87%
Consecutive Div Years 16 yrs
Valuation
P/E Ratio -0.18 Forward P/E 2.70
P/B Ratio N/A P/S Ratio 0.07
PEG Ratio N/A Forward PEG 0.05
EV/EBITDA 0.70 Fwd EV/EBITDA N/A
Forward P/S 0.08 Fwd Earnings Yield 37.04%
FCF Yield N/A
Market Cap 202.94 M Enterprise Value 170.11 M
Per Share
EPS (Diluted TTM) -14.31 Revenue / Share 36.13
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6.91% FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum -47.08

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.76 B 10.70 B 10.33 B 9.96 B 9.79 B
Net Income -1.10 B -362.69 M -41.30 M 22.39 M 221.59 M
EPS (Diluted) -14.31 -4.73 -0.54 0.29 2.94
Gross Profit 2.22 B 2.13 B 1.83 B 1.51 B
Operating Income 27.46 M -207.77 M 104.51 M 142.91 M 368.47 M
EBITDA
R&D Expenses 13.00 M 13.20 M
SG&A Expenses 1.07 B 1.91 B 1.81 B 1.63 B 1.12 B
D&A 214.52 M 264.78 M 287.38 M 228.67 M 90.62 M
Interest Expense 107.18 M 143.80 M 157.92 M 128.89 M 48.09 M
Income Tax 729,000.0 5.33 M -13.43 M -11.50 M 55.17 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.45 B 4.66 B 5.09 B 5.39 B 3.54 B
Total Liabilities 2.91 B 4.09 B 4.17 B 4.44 B 2.60 B
Shareholders' Equity -460.98 M 565.23 M 924.17 M 945.60 M 938.50 M
Total Debt
Cash & Equivalents 281.99 M 49.38 M 243.04 M 69.47 M 55.71 M
Current Assets 547.87 M 2.02 B 2.10 B 2.30 B 2.32 B
Current Liabilities 947.08 M 1.87 B 1.89 B 1.57 B 1.34 B